Replies to post #13819 on Aurinia Pharmaceuticals Inc (AUPH)

[Whalatane]

05:23 PM EDT, 10/26/2021 (MT Newswires) -- Robert Bindert Huizinga, EVP of Research, on October 25, 2021, sold 130,000 shares in Aurinia Pharmaceuticals ( AUPH.) for $3,867,500.
Following the Form 4 filing with the SEC, Huizinga has control over a total of 65,728 shares of the company, with 65,728 shares held directly.
The market value of the direct and indirect holding, based on the transaction price, is approximately $1,955,408.

Thats one of the largest preplanned ( 10b-5 ) sales I've ever seen in a small biotech IF thats what it was

I'm long AUPH ...but this is not want I want to see with BO talks in the air

Kiwi
update
Yes Schwab confirms

. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.